Merck & Company, Inc. · NYSE:MRK
DeLuca Richard R. sold 6,050 Merck & Company, Inc. shares (Form 4)
Traded Aug 6, 2026 · Filed Aug 10, 2026
On Aug 6, 2026, DeLuca Richard R. (EVP&Pres, Merck Animal Heallth) sold 6,050 Merck & Company, Inc. shares at an average US$130.37 for US$789K, leaving 155,487 shares. Filed Aug 10, 2026 (Form 4).
- Sold
- 6,050 shares
- Price
- US$130.37 average (US$130.23 to US$131.02)
- Value
- US$789K
- Holding after
- 155,487 shares
- Trading plan
- No
- Role
- EVP&Pres, Merck Animal Heallth
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | Sale | 805 | US$131.02 | 160,732 | Direct |
| Aug 6, 2026 | Common Stock | Sale | 4,945 | US$130.23 | 155,787 | Direct |
| Aug 6, 2026 | Common Stock | Sale | 300 | US$131.02 | 155,487 | Direct |
Source
Related
- Merck & Company, Inc.
- DeLuca Richard R.
- Merck & Company, Inc. shareholders
- Form 4 · DeLuca Richard R. · Aug 12, 2026
- Form 4 · DeLuca Richard R. · May 1, 2026
- Form 4 · Guindo Chirfi · Aug 13, 2026
- Form 4 · Zachary Jennifer · Aug 13, 2026
- Form 4 · Guindo Chirfi · Aug 7, 2026
- Form 4 · Maraldo David R. · Aug 7, 2026
- Form 4 · Williams David Michael · Aug 7, 2026